Development of sensitive immunoassays for free and total human glandular kallikrein 2

Clinical Chemistry
Ville VaisanenK Pettersson

Abstract

Free and total human kallikrein 2 (hK2) might improve the discrimination between prostate cancer and benign prostatic hyperplasia. Concentrations of hK2 are 100-fold lower than concentrations of prostate-specific antigen (PSA); therefore, an hK2 assay must have a low detection limit and good specificity. PSA- and hK2-specific monoclonal antibodies were used in solid-phase, two-site immunofluorometric assays to detect free and total hK2. The total hK2 assay used PSA-specific antibodies to block nonspecific signal. The capture antibody of the free hK2 assay did not cross-react with PSA. To determine the hK2 concentrations in the male bloodstream, total hK2 was measured in a control group consisting of 426 noncharacterized serum samples. Free and total hK2 were measured in plasma from 103 patients with confirmed prostate cancer. All 426 males in the control group had a total hK2 concentration above the detection limit of 0.0008 microg/L. The median total hK2 concentration was 0.022 microg/L (range, 0.0015-0.37 microg/L). hK2 concentrations were 0.1-58% of total PSA (median, 3.6%). hK2 concentrations were similar in men 41-50 and 51-60 years of age. The ratio of hK2 to PSA steadily decreased from 5-30% at PSA <1 microg/L to 1-2% at...Continue Reading

References

Oct 1, 1987·DNA·L J SchedlichB J Morris
Jan 1, 1994·Breast Cancer Research and Treatment·E P DiamandisD J Sutherland
Aug 24, 1995·Biochemical and Biophysical Research Communications·J LövgrenA Lundwall
Feb 1, 1994·Molecular and Cellular Endocrinology·J A Clements
Dec 14, 1995·Biochimica Et Biophysica Acta·D DeperthesJ Y Dubé
Feb 1, 1996·Clinical Endocrinology·J A ClementsP J Fuller
Jan 3, 1997·Clinica Chimica Acta; International Journal of Clinical Chemistry·C Becker, H Lilja
Feb 11, 1997·Biochimica Et Biophysica Acta·G FrenetteJ Y Dubé
Sep 23, 1997·Biochemical and Biophysical Research Communications·J LövgrenH Lilja
Mar 21, 1998·The Journal of Urology·G FrenetteJ Y Dubé
Oct 6, 1998·Critical Reviews in Clinical Laboratory Sciences·H G RittenhouseA W Partin
Dec 16, 1998·Blood Cells, Molecules & Diseases·M J Heeb, F España
Apr 21, 1999·International Journal of Cancer. Journal International Du Cancer·S D MikolajczykM S Saedi
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R K NamS A Narod
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·K RajakoskiM Karp
Feb 1, 2003·Clinical Chemistry·Bert G BlijenbergFritz H Schröder
Mar 26, 2003·Clinical Chemistry·Alexander HaeseDaniel W Chan

❮ Previous
Next ❯

Citations

Jun 29, 2013·Seminars in Oncology·Tapan BhavsarRuth Birbe
Aug 11, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carsten StephanEleftherios P Diamandis
Aug 18, 2005·BJU International·Carsten StephanEleftherios P Diamandis
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Sven WenskeHans Lilja
Apr 6, 2011·Luminescence : the Journal of Biological and Chemical Luminescence·Jieli TangYihua Zhang
Mar 18, 2016·EJNMMI Research·O Vilhelmsson TimmermandSe Strand
Jul 18, 2006·Urology·Ville VäisänenMartti Nurmi
Sep 25, 2017·Journal of Circulating Biomarkers·Anatilde Gonzalez GuerricoGeorge Klee
Jun 14, 2020·Proceedings of the National Academy of Sciences of the United States of America·Mesude BicakDavid Ulmert
Sep 27, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel L J ThorekDavid Ulmert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.